CATHETER PLACEMENT side effect
What is CATHETER PLACEMENT ?Drugs associated with CATHETER PLACEMENT
CERTICAN DIOVAN EXELON FABRAZYME FORASEQ GLEEVEC LIPITOR LOSARTAN SANDIMMUNE STARLIX TEKTURNA ZOLADEXCATHETER PLACEMENT : Exelon Side Effects Report #5650765-6
Physician from UNITED STATES reported EXELON problem on Feb 25, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, renal failure acute, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Exelon Side Effects Report #5614988-4
EXELON problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Diovan Side Effects Report #5621774-8
Consumer or non-health professional from reported DIOVAN HCT problem on Jan 30, 2008. Female patient, 56 years of age, was diagnosed with hypertension and was treated with DIOVAN HCT. After drug was administered, patient experienced the following problems/side effects: catheter placement, kidney infection, surgery, . DIOVAN HCT dosage: 1 TABLET PER DAY (160/25 MG). Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Exelon Side Effects Report #5624919-9
EXELON problem was reported by a Physician from UNITED STATES on Feb 05, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Starlix Side Effects Report #5571501-8
Consumer or non-health professional from BRAZIL reported STARLIX problem on Dec 11, 2007. Female patient, 79 years of age, weighting 185.2 lb, was diagnosed with diabetes mellitus, hypertension and was treated with STARLIX. After drug was administered, patient experienced the following problems/side effects: catheter placement, . STARLIX dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM, AMLODIPINE, TICLID, CRESTOR, METFORMIN, ATENOLOL, BENERVA, TRILEPTAL. Patient recovered.
CATHETER PLACEMENT : Starlix Side Effects Report #5572863-8
STARLIX problem was reported by a Consumer or non-health professional from BRAZIL on Dec 18, 2007. Female patient, 79 years of age, weighting 185.2 lb, was diagnosed with diabetes mellitus, hypertension and was treated with STARLIX. After drug was administered, patient experienced the following problems/side effects: catheter placement, hyperglycaemia, . STARLIX dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM, AMLODIPINE, TICLID, CRESTOR, METFORMIN, ATENOLOL, BENERVA, TRILEPTAL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Starlix Side Effects Report #5573269-8
Consumer or non-health professional from BRAZIL reported STARLIX problem on Dec 18, 2007. Female patient, 79 years of age, weighting 185.2 lb, was diagnosed with diabetes mellitus, hypertension and was treated with STARLIX. After drug was administered, patient experienced the following problems/side effects: catheter placement, . STARLIX dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM, AMLODIPINE, TICLID, CRESTOR, METFORMIN, ATENOLOL, BENERVA, TRILEPTAL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Diovan Side Effects Report #5524498-0
DIOVAN TRIPLE problem was reported by a Consumer or non-health professional from ARGENTINA on Nov 14, 2007. Male patient, 45 years of age, was diagnosed with hypertension and was treated with DIOVAN TRIPLE. After drug was administered, patient experienced the following problems/side effects: catheter placement, . DIOVAN TRIPLE dosage: unknown. Patient recovered.
CATHETER PLACEMENT : Gleevec Side Effects Report #5477894-4
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Oct 01, 2007. Male patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: catheter placement, cough, fluid retention, haemoptysis, hepatic cirrhosis, hiccups, . GLEEVEC dosage: 300 MG, TID. Patient was hospitalized. Patient died on 06/28/2006.
CATHETER PLACEMENT : Foraseq Side Effects Report #5483331-6
FORASEQ problem was reported by a Consumer or non-health professional from BRAZIL on Oct 08, 2007. Female patient was diagnosed with hypersensitivity and was treated with FORASEQ. After drug was administered, patient experienced the following problems/side effects: catheter placement, respiratory failure, . FORASEQ dosage: unknown. Patient was hospitalized. Patient died.
CATHETER PLACEMENT : Gleevec Side Effects Report #5615278-6
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Jan 31, 2008. Male patient, 76 years of age, weighting 189.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, catheter placement, cough, fluid retention, haemoptysis, hepatic cirrhosis, hiccups, thrombocytopenia, . GLEEVEC dosage: unknown. Patient was hospitalized. Patient died on 06/28/2006.
CATHETER PLACEMENT : Lipitor Side Effects Report #5558791-2
LIPITOR problem was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Female patient, weighting 134.9 lb, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: cardiac operation, catheter placement, dyspnoea, stent placement, transient ischaemic attack, . LIPITOR dosage: unknown. During the same period patient was treated with LOPRESSOR, POTASSIUM CHLORIDE, PRINIVIL, DILANTIN, CALCIUM, VITAMINS, FISH OIL, WARFARIN. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Gleevec Side Effects Report #5577662-9
Physician from GERMANY reported GLEEVEC problem on Dec 21, 2007. Male patient, 56 years of age, was diagnosed with bile duct cancer and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: candidiasis, catheter placement, escherichia infection, heparin-induced thrombocytopenia, hypokalaemia, hyponatraemia, liver abscess, pyrexia, sepsis, . GLEEVEC dosage: 600 MG, QD. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Zoladex Side Effects Report #5420675-8
ZOLADEX problem was reported by a Physician from UNITED KINGDOM on Aug 07, 2007. Male patient, 51 years of age, weighting 198.4 lb, was diagnosed with metastases to bone and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: bladder catheterisation, catheter placement, nocturia, urinary tract obstruction, . ZOLADEX dosage: 10.8 MG. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, ZOL V ZOL, CASODEX. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Zoladex Side Effects Report #5420676-X
Physician from UNITED KINGDOM reported ZOLADEX problem on Aug 07, 2007. Male patient, 51 years of age, weighting 198.4 lb, was diagnosed with metastases to bone and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: bladder catheterisation, catheter placement, nocturia, urinary tract obstruction, . ZOLADEX dosage: 10.8 MG. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, ZOL V ZOL, CASODEX. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Fabrazyme Side Effects Report #5425845-0
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2007. Female patient, 59 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, catheter placement, . FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Sandimmune Side Effects Report #5375852-1
Physician from GERMANY reported SANDIMMUNE problem on June 19, 2007. Male patient, 32 years of age, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, catheter placement, laparotomy, lung disorder, post procedural haemorrhage, renal failure, respiratory failure, tracheostomy, . SANDIMMUNE dosage: 100 - 200 MG/DAY. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Sandimmune Side Effects Report #5375852-1
SANDIMMUNE problem was reported by a Physician from GERMANY on June 19, 2007. Male patient, 32 years of age, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, catheter placement, laparotomy, lung disorder, post procedural haemorrhage, renal failure, respiratory failure, tracheostomy, . SANDIMMUNE dosage: 100 - 200 MG/DAY. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Tekturna Side Effects Report #5630082-0
Consumer or non-health professional from UNITED STATES reported TEKTURNA problem on Feb 12, 2008. Male patient, 79 years of age, was treated with TEKTURNA. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, blood creatinine increased, catheter placement, computerised tomogram abnormal, dialysis, renal disorder, renal failure acute, . TEKTURNA dosage: unknown. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Certican Side Effects Report #5583835-1
CERTICAN problem was reported by a Physician from UNITED STATES on Dec 28, 2007. Male patient, 58 years of age, weighting 224.9 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood creatinine increased, catheter placement, deep vein thrombosis, extrasystoles, hydronephrosis, kidney transplant rejection, lung infiltration, . CERTICAN dosage: unknown. During the same period patient was treated with NEORAL, THYMOGLOBULIN. Patient was hospitalized and became disabled. Patient recovered.
CATHETER PLACEMENT : Certican Side Effects Report #5593422-7
Physician from UNITED STATES reported CERTICAN problem on Jan 07, 2008. Male patient, 58 years of age, weighting 224.9 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood creatinine increased, catheter placement, deep vein thrombosis, extrasystoles, febrile neutropenia, hydronephrosis, kidney transplant rejection, . CERTICAN dosage: unknown. During the same period patient was treated with NEORAL, THYMOGLOBULIN. Patient was hospitalized and became disabled. Patient recovered.
CATHETER PLACEMENT : Tekturna Side Effects Report #5604149-7
TEKTURNA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Male patient, 79 years of age, was treated with TEKTURNA. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, blood creatinine increased, catheter placement, computerised tomogram abnormal, dialysis, renal disorder, renal failure acute, . TEKTURNA dosage: unknown. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Certican Side Effects Report #5531466-1
Physician from UNITED STATES reported CERTICAN problem on Nov 20, 2007. Male patient, 58 years of age, weighting 224.9 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood creatinine increased, catheter placement, deep vein thrombosis, extrasystoles, hydronephrosis, kidney transplant rejection, lung infiltration, . CERTICAN dosage: unknown. During the same period patient was treated with NEORAL, THYMOGLOBULIN. Patient was hospitalized and became disabled. Patient recovered.
CATHETER PLACEMENT : Losartan Side Effects Report #5486323-6
LOSARTAN POTASSIUM problem was reported by a Consumer or non-health professional from NORWAY on Oct 09, 2007. Male patient, 69 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with LOSARTAN POTASSIUM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, catheter placement, circulatory collapse, diarrhoea, hyperventilation, lactic acidosis, nephrolithiasis, . LOSARTAN POTASSIUM dosage: 50 MG, UNK. During the same period patient was treated with METFORMIN, ESIDRIX. Patient was hospitalized. Patient recovered.
CATHETER PLACEMENT : Losartan Side Effects Report #5487711-4
Consumer or non-health professional from NORWAY reported LOSARTAN POTASSIUM problem on Oct 11, 2007. Male patient, 69 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with LOSARTAN POTASSIUM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, catheter placement, circulatory collapse, diarrhoea, hyperventilation, lactic acidosis, nephrolithiasis, . LOSARTAN POTASSIUM dosage: 50 MG, UNK. During the same period patient was treated with METFORMIN, ESIDRIX. Patient was hospitalized. Patient recovered.